Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Sentinel Lymph Node Detection in Patients with Cervical Cancer

Identifieur interne : 009D39 ( Main/Exploration ); précédent : 009D38; suivant : 009D40

Sentinel Lymph Node Detection in Patients with Cervical Cancer

Auteurs : Sabine Malur [Allemagne] ; Norman Krause [Allemagne] ; Christhardt Köhler [Allemagne] ; Achim Schneider [Allemagne]

Source :

RBID : ISTEX:0B231D30E2952C8815FB1F86187AE614715A44B6

English descriptors

Abstract

Purpose. We investigated the validity of sentinel lymph node (SLN) detection after radioactive isotope and/or blue dye injection in patients with cervical cancer. Patients and methods. Between December 1998 and May 2000, 50 patients (mean age 44 years) with cervical cancer FIGO stage I (n = 32), stage II (n = 16), or stage IV (n = 2) underwent SLN detection during primary operation (radical laparoscopic–vaginal or abdominal hysterectomy, exenteration). The day before surgery 1 ml of Albu-Res labeled with 50 MBq Technetium 99m was applied into the cervix at 300, 600, 900, and 1200. Blue dye injection (Patentblue) occurred intraoperatively into the cervix at the same locations. Results. The detection rate of SLN was 78%. Ten patients (20.0%) were diagnosed with lymph node metastases. No SLN was detected in 10 patients, of which 4 patients had positive lymph nodes. Sensitivity and negative predictive value were 83.3 and 97.1%, respectively. The false-negative rate was 16.6% (1 of 6 patients). After the combined injection, the detection rate, sensitivity, and negative predictive values were 100%. A mean of 2.7 pelvic and 2.6 para-aortic SLNs were detected. Para-aortic SLNs were located in the paracaval region in 66.6%, whereas pelvic SLNs were detected in 25.7% at the origin of the uterine artery and in 24.7% at the division of the common iliac artery. Conclusion. A combination of radioactively labeled albumin with blue dye allows successful detection of SLN in patients with cervical cancer. The clinical validity of this technique must be evaluated prospectively.

Url:
DOI: 10.1006/gyno.2000.6041


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Sentinel Lymph Node Detection in Patients with Cervical Cancer</title>
<author>
<name sortKey="Malur, Sabine" sort="Malur, Sabine" uniqKey="Malur S" first="Sabine" last="Malur">Sabine Malur</name>
</author>
<author>
<name sortKey="Krause, Norman" sort="Krause, Norman" uniqKey="Krause N" first="Norman" last="Krause">Norman Krause</name>
</author>
<author>
<name sortKey="Kohler, Christhardt" sort="Kohler, Christhardt" uniqKey="Kohler C" first="Christhardt" last="Köhler">Christhardt Köhler</name>
</author>
<author>
<name sortKey="Schneider, Achim" sort="Schneider, Achim" uniqKey="Schneider A" first="Achim" last="Schneider">Achim Schneider</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0B231D30E2952C8815FB1F86187AE614715A44B6</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1006/gyno.2000.6041</idno>
<idno type="url">https://api.istex.fr/document/0B231D30E2952C8815FB1F86187AE614715A44B6/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000523</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000523</idno>
<idno type="wicri:Area/Istex/Curation">000523</idno>
<idno type="wicri:Area/Istex/Checkpoint">002A41</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002A41</idno>
<idno type="wicri:doubleKey">0090-8258:2001:Malur S:sentinel:lymph:node</idno>
<idno type="wicri:Area/Main/Merge">00A191</idno>
<idno type="wicri:Area/Main/Curation">009D39</idno>
<idno type="wicri:Area/Main/Exploration">009D39</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Sentinel Lymph Node Detection in Patients with Cervical Cancer</title>
<author>
<name sortKey="Malur, Sabine" sort="Malur, Sabine" uniqKey="Malur S" first="Sabine" last="Malur">Sabine Malur</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Gynecology, Friedrich-Schiller-University, 07740, Jena</wicri:regionArea>
<wicri:noRegion>07740, Jena</wicri:noRegion>
<wicri:noRegion>Jena</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Krause, Norman" sort="Krause, Norman" uniqKey="Krause N" first="Norman" last="Krause">Norman Krause</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Gynecology, Friedrich-Schiller-University, 07740, Jena</wicri:regionArea>
<wicri:noRegion>07740, Jena</wicri:noRegion>
<wicri:noRegion>Jena</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kohler, Christhardt" sort="Kohler, Christhardt" uniqKey="Kohler C" first="Christhardt" last="Köhler">Christhardt Köhler</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Gynecology, Friedrich-Schiller-University, 07740, Jena</wicri:regionArea>
<wicri:noRegion>07740, Jena</wicri:noRegion>
<wicri:noRegion>Jena</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schneider, Achim" sort="Schneider, Achim" uniqKey="Schneider A" first="Achim" last="Schneider">Achim Schneider</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Gynecology, Friedrich-Schiller-University, 07740, Jena</wicri:regionArea>
<wicri:noRegion>07740, Jena</wicri:noRegion>
<wicri:noRegion>Jena</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Gynecologic Oncology</title>
<title level="j" type="abbrev">YGYNO</title>
<idno type="ISSN">0090-8258</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">80</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="254">254</biblScope>
<biblScope unit="page" to="257">257</biblScope>
</imprint>
<idno type="ISSN">0090-8258</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0090-8258</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>cervical cancer</term>
<term>sentinel lymph node</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Purpose. We investigated the validity of sentinel lymph node (SLN) detection after radioactive isotope and/or blue dye injection in patients with cervical cancer. Patients and methods. Between December 1998 and May 2000, 50 patients (mean age 44 years) with cervical cancer FIGO stage I (n = 32), stage II (n = 16), or stage IV (n = 2) underwent SLN detection during primary operation (radical laparoscopic–vaginal or abdominal hysterectomy, exenteration). The day before surgery 1 ml of Albu-Res labeled with 50 MBq Technetium 99m was applied into the cervix at 300, 600, 900, and 1200. Blue dye injection (Patentblue) occurred intraoperatively into the cervix at the same locations. Results. The detection rate of SLN was 78%. Ten patients (20.0%) were diagnosed with lymph node metastases. No SLN was detected in 10 patients, of which 4 patients had positive lymph nodes. Sensitivity and negative predictive value were 83.3 and 97.1%, respectively. The false-negative rate was 16.6% (1 of 6 patients). After the combined injection, the detection rate, sensitivity, and negative predictive values were 100%. A mean of 2.7 pelvic and 2.6 para-aortic SLNs were detected. Para-aortic SLNs were located in the paracaval region in 66.6%, whereas pelvic SLNs were detected in 25.7% at the origin of the uterine artery and in 24.7% at the division of the common iliac artery. Conclusion. A combination of radioactively labeled albumin with blue dye allows successful detection of SLN in patients with cervical cancer. The clinical validity of this technique must be evaluated prospectively.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
</list>
<tree>
<country name="Allemagne">
<noRegion>
<name sortKey="Malur, Sabine" sort="Malur, Sabine" uniqKey="Malur S" first="Sabine" last="Malur">Sabine Malur</name>
</noRegion>
<name sortKey="Kohler, Christhardt" sort="Kohler, Christhardt" uniqKey="Kohler C" first="Christhardt" last="Köhler">Christhardt Köhler</name>
<name sortKey="Krause, Norman" sort="Krause, Norman" uniqKey="Krause N" first="Norman" last="Krause">Norman Krause</name>
<name sortKey="Schneider, Achim" sort="Schneider, Achim" uniqKey="Schneider A" first="Achim" last="Schneider">Achim Schneider</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009D39 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 009D39 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:0B231D30E2952C8815FB1F86187AE614715A44B6
   |texte=   Sentinel Lymph Node Detection in Patients with Cervical Cancer
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024